Evaluating Stereotactic Body Radiation Therapy for Oligometastatic Disease of the Bone
Clinical trial NCT02880319 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02880319
- Sponsor
- Dana-Farber Cancer Institute
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-29
- Primary completion
- 2022-05-01
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.